Nasdaq announced it will delist CERo Therapeutics Holdings, Inc.’s common stock and warrants. The company’s securities were suspended on Oct. 31, 2025 and have not traded on Nasdaq since then, signaling severe listing/compliance issues and heightened liquidity risk for holders.
Nasdaq announced it will delist CERo Therapeutics Holdings, Inc.’s common stock and warrants. The company’s securities were suspended on Oct. 31, 2025 and have not traded on Nasdaq since then, signaling severe listing/compliance issues and heightened liquidity risk for holders.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment
